https://stock.noler.com/us/stock/melinta-therapeutics-inc-new https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accounts-and-other-receivables-net-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accounts-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accounts-receivable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrued-liabilities-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrued-professional-fees-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrued-rent-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrued-royalties-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accrued-royalties-current-and-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/accumulated-depreciation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/acquisition-bargain-purchase-gain-recognized-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/acquisition-contingent-consideration-arrangements-change-in-amount-of-contingent-consideration-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/acquisition-contingent-consideration-liability-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/acquisitions https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/additional-paid-in-capital https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/advertising-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/amortization https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/amortization-of-financing-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/asset-impairment-charges https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/assets-fair-value-disclosure https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/business-exit-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/buybacks-share-repurchases https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/capital-expenditures https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/capitalized-contract-cost-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-acquired-from-acquisition https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-and-equivalents https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-and-restricted-cash https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-and-restricted-cash-change-excluding-exchange-rate-effect https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-and-restricted-cash-including-disposal-group-and-discontinued-operations https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cash-flow-breakdown https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/common-stock-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/contract-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/contract-with-customer-asset-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/contract-with-customer-liability-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/contracts-revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/conversion-of-stock-amount-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/convertible-debt-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/convertible-long-term-notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/convertible-notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cost-of-goods-sold https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cost-of-revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cover-page-shares-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/cumulative-effect-of-new-accounting-principle-in-period-of-adoption https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/current-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/current-federal-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/current-liabilities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/current-portion-of-long-term-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/current-state-and-local-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-basis-spread-on-variable-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-basis-spread-on-variable-rate-1 https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-carrying-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-conversion-converted-instrument-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-conversion-converted-instrument-shares-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-increase-accrued-interest https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-maturing-in-next-twelve-months https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-maturing-in-year-four https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-maturing-in-year-three https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-maturing-in-year-two https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-repaid https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/debt-unamortized-discount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-federal-income-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-offering-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-rent-credit-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-revenue-2 https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-revenue-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-charitable-contribution-carryforwards https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-deferred-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-goodwill-and-intangible-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-gross https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-gross-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-net-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-operating-loss-carryforwards-foreign https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-operating-loss-carryforwards-state-and-local https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-other https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-other-loss-carryforwards https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-property-plant-and-equipment https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-stock-compensation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-tax-credit-carryforwards https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-tax-credit-carryforwards-other https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-valuation-allowance-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deferred-tax-expense-from-stock-options-exercised https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/defined-contribution-plan-cost-recognized https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/deposits-assets-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/depreciation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/depreciation-and-amortization https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/derivative-liabilities-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/dividends-common-stock https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/dividends-declared https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/effective-tax-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/employee-related-liabilities-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/entity-number-of-employees https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/fair-value-assets-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/fair-value-liabilities-change-in-unrealized-gain-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/fair-value-measurement-with-unobservable-inputs-reconciliations-recurring-basis-liability-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/fair-value-option-changes-in-fair-value-gain-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/federal-income-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/financial-liabilities-fair-value-disclosure https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/financing-cash-flow https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-remainder-of-fiscal-year https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/finite-lived-intangible-assets-fair-value-disclosure https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/form-d-other https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/form-d-stocks https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/gain-contingency-unrecorded-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/gain-loss-on-contract-termination https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/gain-loss-on-disposition-of-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/gain-loss-on-termination-of-lease https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/general-and-administrative-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/goodwill https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/goodwill-impairment-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/impairment-of-intangible-assets-finitelived https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/income-tax https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-accounts-payable-trade https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-contract-with-customer-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-deferred-revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-employee-related-liabilities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-interest-payable-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-inventories https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-other-noncurrent-assets-and-liabilities-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/increase-decrease-in-receivables https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/indefinite-lived-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/insider-transactions-other https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/insider-transactions-other/purchases https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/insider-transactions-stock-options https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/insider-transactions-stock-units https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/insider-transactions-warrants https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/interest-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/interest-expense-on-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/interest-expense-related-party https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/interest-paid-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/interest-payable-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-finished-goods https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-gross https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-raw-materials https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-valuation-reserves https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-work-in-process https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/inventory-write-down https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/investing-cash-flow https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/investment-income-interest https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/lease-and-rental-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/legal-fees https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/lessee-operating-lease-liability-payments-remainder-of-fiscal-year https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/lessee-operating-lease-liability-undiscounted-excess-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/level-3-asset-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/level-3-liability-gain-loss-included-in-earnings https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/level-3-liability-purchases-sales-issuances-settlements https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/level-3-liability-transfers-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/liabilities-fair-value-disclosure https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/liabilities-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/licenses-revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/line-of-credit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/line-of-credit-facility-amount-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/line-of-credit-facility-current-borrowing-capacity https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/line-of-credit-facility-remaining-borrowing-capacity https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/litigation-settlement-amount-awarded-to-other-party https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/litigation-settlement-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/long-term-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/long-term-notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-cash-from-financing-activities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-cash-from-investing-activities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-cash-from-operating-activities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-change-in-cash https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/net-income-loss-available-to-common-stockholders-basic https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/noncash-or-part-noncash-acquisition-intangible-assets-acquired https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/noncash-or-part-noncash-acquisition-value-of-assets-acquired https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/notes-payable-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/number-of-operating-segments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-cash-flow https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-expenses https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-cost https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-impairment-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-liability-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-liability-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-2 https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-after-year-five https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-future-minimum-sublease-rentals https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-year-five https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-year-four https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-year-three https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-payments-due-year-two https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/operating-leases-rent-expense-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-accrued-liabilities-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-assets-miscellaneous-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-income-2 https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-intangible-assets-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-noncash-income-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-noncurrent-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-noncurrent-liabilities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-nonoperating-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-nonoperating-income-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-postretirement-benefit-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-prepaid-expense-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-receivables https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-sales-revenue-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/other-sundry-liabilities-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/paid-in-capital-convertible-debt-with-conversion-feature https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payment-for-contingent-consideration-liability-financing-activities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-for-legal-settlements https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-for-postemployment-benefits https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-of-debt-extinguishment-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-of-debt-issuance-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-to-acquire-held-to-maturity-securities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/postemployment-benefits-liability-current-and-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-shares-facts https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-accretion-of-redemption-discount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-dividend-rate-percentage https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-dividends-and-other-adjustments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-shares-authorized https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-shares-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/preferred-stock-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/prepaid-expense-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/prepaid-insurance https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/pretax-income https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-convertible-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-issuance-initial-public-offering https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-issuance-of-warrants https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-sale-and-maturity-of-held-to-maturity-securities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-stock-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/profit-loss https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/property-plant-and-equipment-gross https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/property-plant-equipment https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/public-float https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/receivables-long-term-contracts-or-programs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/receivables-net-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/repayments-of-notes-payable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/repayments-of-secured-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/research-and-development https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/restricted-cash https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/restricted-cash-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/restructuring-and-related-cost-number-of-positions-eliminated-period-percent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/restructuring-charges https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/retained-earnings https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/revenue https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/revenue-from-contract-with-customer-excluding-assessed-tax https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/revenue-remaining-performance-obligation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/right-of-use-asset-obtained-in-exchange-for-operating-lease-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/sale-of-stock-price-per-share https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/sales-revenue-goods-net https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/security-deposit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/severance-costs https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/sga-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-dividend-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/share-based-goods-and-nonemployee-services-transaction-valuation-method-expected-volatility-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/share-based-goods-and-nonemployee-services-transaction-valuation-method-risk-free-interest-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/share-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/shareholders-equity https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/shares-authorized https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/shares-issued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/shares-issued-shares-new-issues https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/state-and-local-income-tax-expense-benefit https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-purchase-price-of-common-stock-percent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-based-compensation https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-compensation-tax-benefit-from-compensation-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-new-shares-sold https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-value-conversion-of-convertible-securities-net-of-adjustments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-value-share-based-compensation-forfeited https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-exercisable-number https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-expirations-in-period https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-grants-in-period-grant-date-fair-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-outstanding-number https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-vested-and-expected-to-vest-outstanding-aggregate-intrinsic-value https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stock-split-ratio https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-credit-carryforward-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-disposition-of-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-disposition-of-business https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-nondeductible-expense-research-and-development https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-prior-year-income-taxes https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-rate-reconciliation-tax-credits https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-disposition-of-business https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-other-adjustments https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-tax-contingencies-state-and-local https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/tax-reconciliation-tax-credits https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-accretion-of-dividends https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-accretion-to-redemption-value-adjustment https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-carrying-amount-attributable-to-parent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-liquidation-preference https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-shares-authorized https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/temporary-equity-shares-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/total-assets https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/total-contract-liability https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/total-liabilities https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/total-liabilities-and-equity https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/total-long-term-debt https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/unbilled-contracts-receivable https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/unrecognized-tax-benefits https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/utb-income-tax-penalties-and-interest-accrued https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/value-added-tax-receivable-current https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/value-added-tax-receivable-noncurrent https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/warrants-and-rights-outstanding https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/warrants-not-settleable-in-cash-fair-value-disclosure https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/weighted-average-number-of-share-outstanding-basic-and-diluted https://stock.noler.com/us/stock/melinta-therapeutics-inc-new/workers-compensation-discount-amount